{"filing":{"accession_number":"0001171843-26-004606","cik":"0001421876","ticker":"GLPG","company_name":"Lakefront Biotherapeutics NV","form":"6-K","filing_date":"2026-07-13","report_date":null,"primary_document":"f6k_071326.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1421876/000117184326004606/f6k_071326.htm"},"events":[{"id":17629,"run_id":15797,"accession_number":"0001171843-26-004606","anchor_item_number":"EX-99.1","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Dr. Paulo Fontoura has tendered his resignation from the Board of Directors of Lakefront Biotherapeutics following his appointment as Executive Vice President, Global Head of Research \u0026 Development Pharma at Sanofi SA. The principal disclosed action is a director's departure from the board, which is a material governance event affecting the composition of the company's leadership.","company_name":"Lakefront Biotherapeutics NV","ticker":"GLPG","filing_date":"2026-07-13","form":"6-K","submitted_at":null,"items":[{"id":16178,"accession_number":"0001171843-26-004606","item_number":"EX-99.1","item_title":"exh_991.htm","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Dr. Paulo Fontoura has tendered his resignation from the Board of Directors of Lakefront Biotherapeutics following his appointment as Executive Vice President, Global Head of Research \u0026 Development Pharma at Sanofi SA. The principal disclosed action is a director's departure from the board, which is a material governance event affecting the composition of the company's leadership.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-13T20:33:42.087742+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16178,"accession_number":"0001171843-26-004606","item_number":"EX-99.1","item_title":"exh_991.htm","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Dr. Paulo Fontoura has tendered his resignation from the Board of Directors of Lakefront Biotherapeutics following his appointment as Executive Vice President, Global Head of Research \u0026 Development Pharma at Sanofi SA. The principal disclosed action is a director's departure from the board, which is a material governance event affecting the composition of the company's leadership.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-13T20:33:42.087742+00:00","company_name":"Lakefront Biotherapeutics NV","ticker":"GLPG","filing_date":"2026-07-13"}]}